CLIA Complexity Categorization Transfer From CDC To FDA Under Way
This article was originally published in The Gray Sheet
Executive Summary
FDA expects to assume all duties related to the categorization of in vitro diagnostics conducted under the Clinical Laboratory Improvement Amendments from the Centers for Disease Control and Prevention by Jan. 31, 2000.